Novo Nordisk - Accelerating Site Acceptance Testing in Life Science Applications Using Digital Twins and AI

Name: Novo Nordisk - Accelerating Site Acceptance Testing in Life Science Applications Using Digital Twins and AI
Start: 2026-11-18T14:00:00
End: 2026-11-18T15:00:00

Starts: November 18, 2026 at 2:00 PM
Ends: November 18, 2026 at 3:00 PM
Format: Online
Location: VIRTUAL

About This Event

Site Acceptance Testing (SAT) is a critical step in validating that new systems meet performance, quality, and compliance requirements, but it can be both time- and resource-intensive. In this session, Novo Nordisk will share how they are combining Digital Twin technology with AI-driven automation to create digital SATs in Emulate3D. By testing, troubleshooting, and refining acceptance scenarios in a virtual environment before physical deployment, engineers can accelerate validation, improve efficiency, reduce risk, and save valuable project resources.